| Young Investigator Symposium |
09:00~10:10 |
| Session 1 |
Room A |
| 1) A Few Control the Whole: How an Expression Signature from the Tumor Initiating Cell Population in Sarcoma Predicts Clinical Outcome |
| Ilkyu Han (Seoul National University Hospital) |
| 2) Role of Pyknon, Long Noncoding RNA, in Gastrointestinal Cancer |
| Sang Kil Lee (Yonsei University College of Medicine) |
| 3) Copy Number Alternation in Digestive Track and Gastric Adenocarcinoma |
| Byoungyong Shim (St. Vincent's Hospital, The Catholic University) |
| 4) Heat Shock Protein 90 Inhibitors: Is This Promising? |
| Dae Ho Lee (Univ. of Ulsan College of Medicine, Asan Medical Center) |
| Session 2 |
Room B |
| 1) Prevention-oriented Clinical Trial |
| Sue K. Park (Seoul National University College of Medicine) |
| 2) Supportive Care in Oncology |
| Jung Hye Kwon (Hallym University, Kangdong Sacred Heart Hospital) |
| 3) Clinical Research in Palliative Care |
| Jung Hun Kang (Gyeongsang University Hospital) |
| Session 3 |
Room C |
| 1) Expression of Phospho-AMPK and Insulin Receptor in Patients with NSCLC |
| Jin-Soo Kim (Boramae Medical Center) |
| 2) New Conversing Technology; Plasma Medicine |
| Chul-Ho Kim (Ajou University School of Medicine) |
| 3) Myeloid Cells Promote Tumor Recurrence after Radiotherapy |
| G-One Ahn (Pohang University of Science and Technology) |
|
| Plenary Lecture 1 |
10:30~11:10, Room A ~ C |
| Chromatin Dynamics and Epigenetic Reprogramming in Cancer |
| Sung Hee Baek, Ph.D. (School of Biological Sciences, Seoul National University) |
|
| Plenary Lecture 2 |
11:10~12:00, Room A ~ C |
| T Cell Stemness and Cancer Stemness |
| Weiping Zou, MD, Ph.D. (University of Michigan School of Medicine, USA) |
|
| Symposium 1 |
13:20~15:10, Room A |
| Angiogenesis and Circulating Tumor Cell |
| 1) New VEGFR-2 Antagonist VSRC5 for Anti-angiogenesis Therapy |
| Young-Myeong Kim (Kangwon National University School of Medicine) |
| 2) Angiogenesis and Normalization of Tumor Blood Vessels |
| Young-Guen Kwon (Yonsei University) |
| 3) Circulating Tumor Cell in Clinic and Cancer Research |
| Jhingook Kim (Samsung Medical Center) |
| 4) PLS3 is a Novel Marker for Circulating Colorectal Cancer Cells |
| Masaki Mori, M.D. (Osaka University, Japan) |
|
| Symposium 2 |
15:30~17:30, Room A |
| Molecular Pathology in Clinical Practice and Research |
| Joint Symposium (Korean Cancer Association and Korean Society of Pathologists) |
| 1) Molecular Diagnosis of Lung Cancer |
| Jin Haeng Chung (Seoul National University Bundang Hospital) |
| 2) Her-2 Amplification in Breast and Gastric Cancer |
| Young Kyung Bae (Yeung Nam University College of Medicine) |
| 3) Molecular Diagnosis of Gastric Cancer |
| Do Youn Park (Pusan National University School of Medicine) |
| 4) Molecular Diagnosis of Thyroid Cancer |
| Tae Sook Hwang (Konkuk University Medical Center) |
| 5) Molecular Diagnosis of Colon Cancer |
| Jae Hyuk Lee (Chonnam National University Medical School) |
|
| Symposium 3 |
13:20~15:10, Room C |
| Oncogenomics: How to Translate? |
| Joint Symposium (Korean Cancer Association and Korean Genome Organization) |
| 1) Clinical Application of Personal Cancer Genome Data |
| Se-Hoon Lee (Seoul National University College of Medicine) |
| 2) Genome-wide Screening of Microsatellite Instability in Human Colorectal and Endometrial Cancer Genomes |
| Tae-Min Kim (The Catholic University of Korea School of Medicine) |
| 3) Functional Regulatory Element Detected by Epigenetic Changes in Breast Cancer Cells |
| Tae-Young Roh (Pohang University of Science and Technology) |
| 4) Integration of Cancer Genome Data and Their Clinical Application |
| Jongsun Jung (Syntekabio, Inc) |
|
| Symposium 4 |
15:30~17:30, Room C |
| Systems Biology in Cancer Research: Beginning of the Personalized Medicine |
| 1) Integromics for Liver Cancer |
| Hyun Goo Woo (Ajou University School of Medicine) |
| 2) Quantitative Proteomic Screening Identifies Phosphorylation of MIG6 as a key Regulatory Mechanism for Inhibitory Effect on NSCLC-derived mutant EGFR |
| Jeonghee Cho (Samsung Genome Institute, Samsung Medical Center) |
| 3) Prognostic Gene Expression Signature of Colorectal Cancer |
| Sang Cheul Oh (Korea University Guro Hospital) |
| 4) Development of Cancer Subtypes in Large-scale Genomics Data |
| In-Sun Chu (Korea Research Institute of Bioscience & Biotechnology) |
|
| International Session (Oral Presentation) |
13:20~17:30, Room D, E |
|
| Luncheon Symposium 1 |
12:00~13:00, Room A ~ C |
| Palliative Care: Multi-disciplinary Approach for QoL of Cancer Patients |
| Educational Session |
09:00~10:10 |
| 1. Innovative Treatment |
Room A |
| 1) Innovative Treatment in Urologic Malignancies |
| Jae Lyun Lee (Univ. of Ulsan College of Medicine, Asan Medical Center) |
| 2) Innovative Treatment in Hematologic Malignancies |
| Chul Won Jung (Sungkyunkwan University School of Medicine, Samsung Medical Center) |
| 3) Tailored Management of Metastatic Breast Cancer Based on Molecular Subtypes |
| Seock Ah Im (Seoul National University College of Medicine) |
| 2. Short Course Stereotactic Body Radiotherapy (SBRT) for Oligometastases |
Room B |
| 1) SBRT Role for Oligometastases : Expected Survival Benefit |
| Mi-Sook Kim (Korea Institute Radiological & Medical Sciences) |
| 2) Liver & Lung Oligometastases : SBRT vs Surgery |
| Woo Chul Kim (Inha University Hospital) |
| 3) Bone Oligometastases : Role of SBRT |
| Jin Ho Kim (Seoul National University Hospital Integrated Cancer Care Center) |
| 3. Clinical Trials in Surgical Oncology |
Room C |
| 1) How to Design Clinical Trial in Surgical Oncology? |
| Young-Woo Kim (National Cancer Center) |
| 2) How to Standardize and Overcome Variation of Surgical Treatment? |
| Jin-Young Jang (Seoul National University College of Medicine) |
| 3) Role of the Surgeon in an Oncology Trial |
| Gyu Seog Choi (Kyungpook National University Medical Center) |
|
| Plenary Lecture 3 |
10:30~11:10, Room A ~ C |
| Linking "Novel Target Discovery" to Clinic and Pharma |
| Sung Hoon Kim, Ph.D. (Biopharmaceutical Sciences College of Pharmacy, Seoul National University) |
|
| Plenary Lecture 4 |
11:10~12:00, Room A ~ C |
| Novel Therapeutic Strategies for Cancer Stem Cells |
| Hideyuki Saya, M.D. (School of Medicine, Keio University, Japan) |
|
| Symposium 5 |
13:50~15:30, Room A |
| Successful Cooperation between Pharmaceutical & Clinical Researchers in Oncology Drug R&D |
| Joint Symposium (Korean Cancer Association and National OncoVenture) |
| 1) Clinician's Role in the Development of New Anticancer Agents |
| Jung-Yong Kim (National OncoVenture) |
| 2) Innovative Target Discovery for Therapeutic Antibody |
| Youngwoo Park (Korea Research Institute of Bioscience & Biotechnology) |
| 3) Open Innovation and Clinical Development of a Novel Pan-Her Inhibitor Poziotinib |
| Jee Woong Son (Vice President of Hanmi Pharm) |
| 4) Best Development of Cancer Drug by Translating Biologic Discovery into Clinical Trials |
| Ji-Youn Han (National Cancer Center) |
|
| Symposium 6 |
15:50~17:30, Room A |
| Issues in Conducting Clinical Trials between the Cooperative Groups |
| 1) Hurdles and Issues for Conducting Collabolative Clinical Trials with EORTC |
| Hwan Jung Yun (Chungnam National University School of Medicine) |
| 2) Experiences of KGOG in Conducting Clinical Trials of GOG and GCIG |
| Jae Hoon Kim (Yonsei University College of Medicine) |
| 3) KCSG Experience in International Collaboration - Challenges and Opportunities |
| Jee Hyun Kim (Seoul National University Bundang Hospital) |
| 4) Collaboration between KROG and RTOG |
| Kwan Ho Cho (National Cancer Center) |
|
| Symposium 7 |
13:50~15:30, Room C |
| Molecular Imaging for Theragnostics |
| 1) Molecular Imaging for Surgical Resection of Cancer |
| Hyun Koo Kim (Korea University College of Medicine) |
| 2) Programming of Bacteria for Cancer Theragnostics |
| Jung-Joon Min (Chonnam National University Medical School) |
| 3) Radio-theragnostics for Tumor Angiogenesis in a Tumor-bearing Mouse Model and a Pilot Study in Human Patients |
| Byung Chul Lee (Seoul National University Bundang Hospital) |
| 4) Molecular Imaging for Personalized Theragnostics |
| Mei Tian, M.D., Ph.D. (Zhejiang University School of Medicine, China) |
|
| Symposium 8 |
15:50~17:30, Room C |
| Cancer Metabolism |
| 1) Targeting Arginine-dependent Cancers with Pegylated Arginine Deiminase |
Peter Szlosarek, Ph.D.
(Barts Cancer Institute - a Cancer Research UK Centre of Excellence, Queen Mary, University of London, UK) |
| 2) Metabolic Remodelling in Papillary Thyroid Cancer |
| Minho Shong (Chungnam National University School of Medicine) |
| 3) Diagnosis of Cancer Using Metabolomics Method |
| Seung Hong Choi (Seoul National University College of Medicine) |
| 4) Effect of Metformin for Breast Cancer |
| Wonshik Han (Seoul National University College of Medicine) |
|
| Symposium 9 |
13:50~15:30, Room E |
| Current Standard and Future Perspectives in Gynecologic Cancer |
| Joint Symposium (Korean Cancer Association and Korean Society of Gynecologic Oncology) |
| 1) Cervical Cancer Screening Paradigm Shift is Possible? From Cytology to HPV Molecular Diagnostics |
| Jae-Kwan Lee (Korea University Guro Hospital) |
| 2) Improving Ovarian Cancer Screening with Novel Biomarker Algorithm |
| Yong Man Kim (Univ. of Ulsan College of Medicine, Asan Medical Center) |
| 3) Current Clinical Evidence & Future Direction of Molecular Target Therapy in Epithelial Ovarian Cancer |
| Jae Weon Kim (Seoul National University College of Medicine) |
| 4) Retroperitoneal Lymphadnectomy Can be Safely Omitted in Selected Early Stage Endometrial Cancer |
| Sokbom Kang (National Cancer Center) |
|
| Symposium 10 |
15:50~17:30, Room E |
| Research, Clinical Practice and Policy for Cancer Survivorship |
| 1) Updates in Cancer Survivorship Research |
| Dae Ho Lee (Univ. of Ulsan College of Medicine, Asan Medical Center) |
| 2) Updates in Cancer Survivorship Clinical Practice |
| Myong Cheol Lim (National Cancer Center) |
| 3) Research for Cancer Survivorship Health Management in Oncology Nursing Priorities for Research and Development in Oncology Nursing Service |
| Eui Geum Oh (College of Nursing, Yonsei University) |
| 4) Framework for Translating Cancer Survivorship Research into Clinical Practice and Policy |
| Young Ho Yun (Seoul National University Hospital Integrated Cancer Care Center) |
|
| Luncheon Symposium 2 |
12:00~13:00, Room A ~ C |
| Anti-angiogenic Drugs for Colorectal Cancer: Exploring New Possibilities |
| Napoleone Ferrara, M.D. (Moores Cancer Center, University of California, USA) |
